Skip to content

About us
Technology
Product solutions
Laboratory services
Applications
Resources
Investors

Business strategy
Market size
Regulatory news
Share price
Financial reports
Financial Calendar
Corporate responsibility report
Glossary
Email alerts

Corporate governance
Significant shareholders
ADR
Advisors
General meetings documentation

Corporate presentations

CelLBxHealth in the media
Analyst research

Latest report

Interim Report June 2025

Please click the links below to download our Annual and Interim Reports and Financial Statements

For any investor relations queries please contact

investor@cellbxhealth.com

About Us
Technology
Product solutions
Laboratory services
- Discover all Laboratory services
- Immunofluorescence:
Applications
Resources

Investors

For any investor relations queries please contact

investor@cellbxhealth.com

Investor relations

Regulatory news

Investors > Regulatory news

The Parsortix^® platform has the potential to deliver profound improvements in cancer treatment selection and disease monitoring

About us
Technology
Product solutions
Laboratory services
Applications
Resources
Investors

2 Occam Court, Occam Road, Surrey Research Park, Guildford, GU2 7QB, UK +44 (0)1483 343434

5100 Campus Drive, Suite 120, Plymouth Meeting, PA 19462, USA +1 610 233 4712

10 Nugent Road, Surrey Research Park, Guildford, GU2 7AF, UK

© CelLBxHealth 2026

Privacy policy
Cookies declaration
Terms & conditions
Certificates
Security commitments

Request a meeting with

Full name

Email address

Phone number

Preferred date

Preferred time

I agree that by submitting this form, I accept the website’s terms & conditions of use and privacy policy.